Vertex Pharmaceuticals Inc

Bluebird Bio gene therapy sells itself to Carlyle and SK Capital

by

Sopa Images | Lightrocket | Getty Images Bluebird Bio will sell itself to private equity firms Carlyle and SK Capital for about $30 million, the company said Friday, marking the end of the Bluebird’s fall from the one of the buzziest biotech firms to one that was on the cusp of running out of money. … Read more

Sickle cell gene therapies push health plans toward new payment models

by

Starting in his early teens, Deshawn “DJ” Chow wasn’t sure he’d ever be able to live a normal life. Crushing pain episodes brought on by his sickle cell disease were getting progressively worse.    “It’s just been hard skipping school and always being in and out of the hospital,” the 19-year-old said. “And just severe … Read more